-+ 0.00%
-+ 0.00%
-+ 0.00%

Hong Kong stocks strengthened their innovative drug concept. Cansino Biotech rose more than 10%, Jingtai Holdings rose more than 4%, and Pharmacom Kangde and Cinda Biotech followed suit.

智通财经·09/22/2026 02:41:02
语音播报
Hong Kong stocks strengthened their innovative drug concept. Cansino Biotech rose more than 10%, Jingtai Holdings rose more than 4%, and Pharmacom Kangde and Cinda Biotech followed suit.